Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.

Cancer treatment reviews - 1 Jul 2021

Crowley F J, O'Cearbhaill R E, Collins D C

Abstract excerpt

It is estimated that 604,127 patients were diagnosed with cervical cancer worldwide in 2020. While a small percentage of patients will have metastatic disease at diagnosis, a large percentage (15-61%) later develop advanced disease. For this cohort, treatment with systemic chemotherapy remains the standard of care, with a static 5-year survival rate over the last thirty years. Data on targetable molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Precision Medicine

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34082256
DOI: 10.1016/j.ctrv.2021.102225
PMCID: PMC9490510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.PMID 34082256Read ↗

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.Semantic proximity Read ↗

A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.Semantic proximity Read ↗

Cervical Cancer Analysis Reveals New Mutations.Semantic proximity Read ↗

Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting ReportSemantic proximity Read ↗

TP53 Mutants and Non-HPV16/18 Genotypes are Poor Prognostic Factors for Concurrent Chemoradiotherapy in Locally Advanced Cervical CancerSemantic proximity Read ↗

Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care.Semantic proximity Read ↗

Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.Semantic proximity Read ↗

TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.Semantic proximity Read ↗

Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatmentSemantic proximity Read ↗

Somatic Variations in Cervical Cancers in Indian Patients.Semantic proximity Read ↗

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.Semantic proximity Read ↗

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.